Hematopoietic stem and progenitor cells (HSPCs)

21Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hematopoietic stem/progenitor cells (HSPCs) isolated from bone marrow have been successfully employed for 50 years in hematological transplantations. Currently, these cells are more frequently isolated from mobilized peripheral blood or umbilical cord blood. In this chapter, we overview several topics related to these cells including their phenotype, methods for isolation, and in vitro and in vivo assays to evaluate their proliferative potential. The successful clinical application of HSPCs is widely understood to have helped establish the rationale for the development of stem cell therapies and regenerative medicine.

Cite

CITATION STYLE

APA

Bujko, K., Kucia, M., Ratajczak, J., & Ratajczak, M. Z. (2019). Hematopoietic stem and progenitor cells (HSPCs). In Advances in Experimental Medicine and Biology (Vol. 1201, pp. 49–77). Springer. https://doi.org/10.1007/978-3-030-31206-0_3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free